Introduction: Runx2, the master regulator of bone cell development, is essential for proper skeletal morphogenesis and maintenance as its expression is required for osteoblast differentiation and terminal chondrocyte maturation. Germline deletion of Runx2 prevents formation of a mature skeleton, and haploinsufficiency in Runx2 causes defects in intramembranous and endochondral ossification, leading to a cleidocranial dysplasia (CCD) phenotype featuring hypoplastic clavicles and a persistent fontanel in the skull. Axin2 is also a key regulator of skeletal development, acting as a negative feedback inhibitor of canonical Wnt signaling. We recently reported that Runx2 represses Axin2 transcription to promote osteoblast maturation, and that double mutant Axin2-/-: Runx2+/-mice do not have the craniosynostosis phenotype associated with Axin2-deficiency, indicating that Runx2 is essential for enhanced calvarial bone formation in Axin2-/-mice. Primary osteoblasts from double mutant mice resembled wildtype (WT) cultures, intermediate in phenotype between the extreme low and high osteogenic activity of Runx2+/-and Axin2-/-cells, respectively. Interestingly, more in depth analyses revealed persistent cartilage in the frontal suture of double mutant animals, exacerbating the cleidocranial dysplasia phenotype found in Runx2+/-mice, suggesting that Axin2 and Runx2 could be components of the same molecular pathway that regulates endochondral ossification in vivo. To better understand this phenomenon, we investigated developmental and regenerative aspects of skeletal morphogenesis in WT, Axin2-/-, Runx2+/-, and double mutant Axin2-/-: Runx2+/-mice, with an emphasis on understanding interactions between Axin2 and Runx2 in cartilage through analysis of growth plate morphology, primary chondrocyte cultures, and in vivo fracture healing. Methods: Animal studies: All animal research was conducted according to NIH guidelines, and the Mayo Clinic IACUC approved all animal studies. Femurs from 4 week-and 24 week-old male WT, Runx2+/-, Axin2-/-, and double mutant Axin2-/-: Runx2+/-mice were measured to quantify long bone length. Tibias from 4 week -old mice were histologically processed and stained with Safranin O / Fast green. Growth plate morphology was quantified with image analysis software (Bioquant Osteo). Primary immature mouse articular chondrocytes (IMACs) were isolated and cultured in micromass. Cells were fixed after 21 days in culture and stained with either alcian blue (matrix proteoglycans) or alizarin red (calcification). For gene expression studies, mRNA was harvested with TRIzol (Invitrogen) after 21 days in culture and reverse transcribed into cDNA. Expression levels of genes associated with chondrocyte maturation were measured by qPCR. Endochondral fracture repair: Intramedullary fixation was carried out using the trochar of a 25G spinal needle inserted into the femoral medullary canal, after which closed fractures were created using an Einhorn device. X-rays were taken on days 14, 21, and 28 post-fracture. Projected radiographical callus area was quantified with image analysis software. Mice were sacrificed 21 days post-fracture for histological and microCT analysis of the healing femurs, or 30 days after fracture for torsional analysis of bone mechanical strength. For morphological analysis, bones were scanned on a μCT35 scanner (Scanco) at 20 µm resolution (energy settings: 70 kV, 114 µA; threshold: 150) after which they were histologically prepared with Safranin O / Fast green. To quantify torsional strength, the proximal and distal ends of each femur were potted in brass endcaps. Bones were thawed in 0.9% saline for at least one hour and then loaded to failure at an actuator head displacement rate of 1 degree per second on a custom torsion testing apparatus. Ultimate torque was calculated from load-deformation curves. Results: Despite displaying relatively normal growth plate morphology, chondrocyte maturation was impaired in double mutant Axin2-/-: Runx2+/-mice, as chondrocytes arrested at intermediate stages of differentiation and failed to produce a calcified matrix in vitro (Figure 1 ). Consistent with these results, both Runx2+/-and double mutant mice had larger fracture calluses than WT and Axin2-/-mice at early stages of endochondral fracture healing, confirming the dominance of Runx2 (Figure 2 ). Persistent cartilage was observed histologically in the fracture callus of double mutant mice at day 21 after fracture, but was not seen in mice from other groups. By days 28 to 30 after fracture, however, double mutant animals diverged from the Runx2+/-mice, showing smaller callus size and differences in torsional strength indicative of more rapid healing as seen in the Axin2-/-mice ( Figure 2 , Table 1 ). Discussion: Taken together, our data suggest a dominant role for Runx2 in chondrocyte maturation, but implicate Axin2 as an important modulator of the terminal stages of endochondral ossification. Significance: These studies are the first to show a mechanistic link between Runx2 and Axin2 in endochondral ossification, and are clinically relevant because Axin2 is a negative regulator of the Wnt-β-catenin signaling pathway, which is a target for new osteogenic therapies. Acknowledgments: The Mayo Clinic Center for Regenerative Medicine supported this work. The authors thank the Mayo Clinic
